GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report) dropped 8.4% during trading on Monday after Citigroup lowered their price target on the stock from $7.00 to $6.25. Citigroup currently has a buy ...

GoodRx returned to sequential growth in subscribers in Q3, showing potential for profit improvement. Read why I upgrade GDRX ...

Leerink Partners analyst Michael Cherny has maintained their bullish stance on GDRX stock, giving a Buy rating on January 10.Stay Ahead of the ...

GoodRx (NASDAQ:GDRX – Free Report) had its price objective reduced by Citigroup from $7.00 to $6.25 in a research note issued ...

BofA lowered the firm’s price target on GoodRx (GDRX) to $4.25 from $4.50 and keeps an Underperform rating on the shares after the company ...

GoodRx Holdings Inc provides a platform that helps consumers in the United States save on prescription drugs. By offering a price comparison tool, GoodRx enables users to find the best prices for ...

Vandana Singh How Much Did Americans Overspend On Weight Loss Medications in 2024? GoodRx Reveals GoodRx's latest research shows surging demand for weight loss medications like Wegovy and Zepbound ...

Analysts have set 12-month price targets for GoodRx Holdings, revealing an average target of $6.25, a high estimate of $7.00, ...

The stock lost the gains later ... “QSYMIA is available for a low cash price in more than 70,000 retail pharmacy locations ...

InvestingPro analysis suggests the stock is currently trading below ... of pharmacies and competitive prescription prices. What challenges does GoodRx face in maintaining its market position ...

InvestingPro analysis suggests the stock is currently trading below its Fair Value ... who rely on the platform for access to a wide network of pharmacies and competitive prescription prices. What ...